The Global Covid-19 Saliva Screening Test Potential Market Size, Share & Growth Analysis By Location (Travel Stations), By Technology, By Mode (Centralized Testing, Decentralized Testing), And Regional Forecast, 2021-2023, This research & consulting report doles out information about the global COVID-19 Saliva Screening Test Potential market. The forecast period of the market extends till 2023, while commencing in 2020. The report sheds light on various key insights & trends that have occupied center stage & drawn the attention of end-users. The COVID-19 Saliva Screening Test Potential industry is witnessing impressive expansion at present, having logged double digit CAGRs in the past.
COVID-19 saliva screening test potential market size was valued at USD 2955.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.8% from 2021 to 2028. These estimates represent a potential market size for the COVID-19 saliva screening test in a scenario where end-use locations have a 60.0% population attendance (60% of pre-COVID attendance) and testing rate using COVID-19 saliva screening test device is 100.0%. Saliva-based screening for SARS_CoV-2 is gaining traction in the current scenario, as it is easy to use, patient-friendly, and has a shorter test-to-result timeline.
The report alludes to the COVID-19 Saliva Screening Test Potential market as a lucrative sector. This sector is slated to generate substantial revenues during forecast period 2021 to 2023. The analytical report highlights data & overview regarding the size, shares, & demand of COVID-19 Saliva Screening Test Potential. Several other factors have had a positive or negative impact on the industry, all of which have been laid out in details.
The said factors comprise drivers, novel prospects, hindrances, and other vital characteristics of the market. Investments by rivals into COVID-19 Saliva Screening Test Potential products have catapulted the market into limelight & have stoked its demand, globally.
Few among other key aspects that find a mention; encompass the industry segments, predictions, & size and shares for 2021 to 2023. Besides these; the report narrows down on the innovative trends & technological developments, expansion strategies of key players, and regional statistics.
The manner in which nascent & local competitors stack up against prominent players, hogs the spotlight. Novel products & services, coupled with the monetary shares of eminent competitors and the SWOT analysis unveil the complexities of the global industry size.
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends from 2021 to 2023 in each of the sub segments. For the purpose of this study, Eternity Insights has segmented the global COVID-19 Saliva Screening Test Potential market on the basis of location, technology, mode and region:
Research methodology is an integral component of any kind of high-level market research. It entails evaluation by expert panels, research on secondary & primary levels, checks on quality, & testing on completion. Secondary research deeply focuses on the whys, whos, wheres, whens, & hows and caters to answering the strictly consumer-centric base of people.
Some other secondary research sources comprise governmental affiliations & blogs, business magazines, and industrial journals. Primary research includes face-to-face & telephonic interviews with industry experts. It is comparatively more detailed & lays stress on unprejudiced opinions about the products & services.
Primary research findings cement secondary research & help end-users & businesses get a better hang of various markets. It is a well-established fact, though, that research methodology is best implemented through the mixed execution of its aforementioned procedures.
What Does the Report Offer?
Other Vital Points That Are Covered
The market report also brings to light major opportunities and untapped geographies. It is more like a blend of customized research documents & conventional reports. Besides informing buyers about the pros & cons of direct and indirect sales channels, the analysis exhibits illustrations & graphical representations of industry growth and the innovative trends within the industry.
Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Scope
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Eternity Insights internal database
1.3.3 Secondary sources
1.3.3.1 List of secondary data sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Market Model
1.7 Model Details
1.7.1 Location scope
1.7.1.1 Travel stations
1.7.1.1.1 Airports
1.7.1.1.2 Ports & Cruise
1.7.1.1.3 Train Stations
1.7.1.1.4 Border crossings
1.7.1.2 Sports arenas
1.7.1.3 Entertainment venues
1.7.1.4 Universities & Colleges
1.7.1.5 Corporate Campus Environments and Factories
1.7.2 Technology scope
1.7.2.1 FDA recommendations for the use of diagnostic tests for screening
1.7.3 Region-wise market: Base estimates
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Market Summary
Chapter 3 COVID-19 Saliva Screening Test Potential Market: Industry Outlook
3.1 Fluorescence-labeled antigen/antibodies testing: Opportunity Analysis
3.1.1 Competitive products analysis
3.1.1.1 Competitive analysis- COVID-19 POC testing
3.2 Market Dynamics
3.2.1 Market driver analysis
3.2.1.1 Advantages of using saliva as a diagnostic specimen
3.2.1.2 Increasing product approvals by regulatory agencies
3.2.1.3 Paradigm shift toward point-of-care testing
3.2.2 Market restraint analysis
3.2.2.1 High penetration of swab-based testing methods
3.2.2.2 Limitations related to the methodological approach
3.2.3 Market opportunity analysis
3.2.3.1 Safe, quick, and economical nature of saliva-based COVID-19 tests
3.2.4 Market challenge analysis
3.2.4.1 Challenges pertaining to COVID-19 testing in healthcare settings
3.3 Comparative Analysis
3.3.1 Saliva testing versus swab-based RT-PCR testing
3.3.1.1 Global swab-based COVID-19 Diagnostics market, 2020 – 2027 (USD Million)
3.3.2 Saliva testing versus other antigen testing
3.4 Competitive Analysis
3.4.1 Major deals &strategic alliances analysis
3.4.1.1 Technology collaboration & licensing partnership
3.4.1.2 Distribution partnership
3.4.2 Strategy framework
3.4.3 Company participant categorization
3.4.4 Product approval/EUA authorizations& launch timeline
Chapter 4 COVID-19 Saliva Screening Test Potential Market: Location Estimates & Trend Analysis (U.S. & Canada)
4.1 Travel Stations
4.1.1 Airports
4.1.2 Cruise
4.1.3 Port
4.1.4 Train stations
4.1.5 Border crossing
4.2 Sports Arenas
4.3 Concert Halls
4.4 Shopping Malls and Centers
4.5 Amusement Parks
4.6 Corporate Campus Environment
4.7 Universities and Colleges
4.8 Factories
4.8.1 Food processing plants
4.8.2 Meat packing plants
4.8.3 Pharmaceutical plants
4.8.4 Mining
4.8.5 Retail working warehouses
Chapter 5 COVID-19 Saliva Screening Test Potential Market: Location Estimates & Trend Analysis (Other Regions)
5.1 Travel Stations
5.2 Sport Arenas
5.3 Entertainment Venues
5.4 Corporate Environments
5.5 Universities & Colleges
5.6 Factories
Chapter 6 COVID-19 Saliva Screening Test Potential Market: Technology Estimates & Trend Analysis
6.1 COVID-19 Saliva Screening Market: Technology Movement Analysis
6.2 Fluorescence-labeled antigen/antibodies testing
6.2.1 Overview
6.2.2 Key strategic intiatives
6.3 RT-PCR
6.3.1 Technical viewpoint
6.3.2 Future potential
6.3.3 Commercial viewpoint
6.4 CRISPR-Cas9
6.4.1 Technical viewpoint
6.4.2 Future potential
6.4.3 Commercial viewpoint
Chapter 7 COVID-19 Saliva Screening Test Potential Market: Mode Estimates & Trend Analysis
7.1 COVID-19 Saliva Screening Test Potential Market: Mode Movement Analysis
7.2 Centralized Testing (Labs, Hospitals, Clinics)
7.3 Decentralized Testing (Mobile Testing, At-home Testing, Others)
Chapter 8 Regional Business Analysis
8.1 COVID-19 Saliva Screening Test Potential Market: Regional Movement Analysis, 2020 & 2023
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.4 Asia Pacific
8.5 Rest of the World
Chapter 9 Company Profiles
9.1 Company Profiles
9.1.1 ARUP Laboratories.
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Vatic Health
9.1.2.1 Company overview
9.1.2.2 Product benchmarking
9.1.2.3 Strategic initiatives
9.1.3 Mogene
9.1.3.1 Company overview
9.1.3.2 Financial performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 Psomagen, INC.
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 DXTERITY Diagnostics, INC.
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 KONICA MINOLTA, INC.
9.1.6.1 Company overview
9.1.6.2 Ambry Genetics
9.1.6.2.1 Company overview
9.1.6.3 Financial performance
9.1.6.3.1 Financial performance
9.1.6.4 Product benchmarking
9.1.6.5 Strategic initiatives
9.1.7 Fluidigm Corporation
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Phosphorus Diagnostics LLC
9.1.8.1 Company overview
9.1.8.2 Product benchmarking
9.1.8.3 Strategic initiatives
9.1.9 Gravity Diagnostics
9.1.9.1 Company overview
9.1.9.2 Product benchmarking
9.1.9.3 Strategic initiatives
9.1.10 OraSure Technologies
9.1.10.1 Company overview
9.1.10.2 DNA Genotek, Inc.
9.1.10.2.1 Company overview
9.1.10.3 Financial performance
9.1.10.3.1 Financial performance
9.1.10.4 Product benchmarking
9.1.10.5 Strategic initiatives
9.1.11 Quidel Corporation
9.1.11.1 Company overview
9.1.11.2 Financial performance
9.1.11.3 Product benchmarking
9.1.11.4 Strategic initiatives
9.1.12 ABBOTT
9.1.12.1 Company overview
9.1.12.2 Financial performance
9.1.12.3 Product benchmarking
9.1.12.4 Strategic initiatives
9.1.13 LumiraDX
9.1.13.1 Company overview
9.1.13.2 Financial performance
9.1.13.3 Product benchmarking
9.1.13.4 Strategic initiatives
9.1.14 FluroTech Ltd.
9.1.14.1 Company overview
9.1.14.2 Financial performance
9.1.14.3 Product benchmarking
9.1.14.4 Strategic initiatives
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing